Abstract:The excessive inflammation triggered by damage-associated molecular patterns (DAMPs) after myocardial infarction (MI) is responsible for the development of cardiac dysfunction and adverse remodeling, while the mechanisms by which inflammation is fine tuned remain to be fully elucidated. MicroRNA-21 (miR-21) has been shown to function in cardiovascular diseases, while its role in inflammatory responses and cardiac function post MI in mice remains unknown. Here, we found that miR-21 expression was markedly increased in border and infarct areas of cardiac tissues during the early inflammatory phase of MI model established by ligating the left-anterior descending coronary artery. MiR-21 knockout mice had decreased survival rates, worse cardiac dysfunction, and increased infarct and scar areas after MI compared with WT mice. MiR-21 knockout mice showed significantly higher levels of inflammatory cytokines including IL-1β, IL-6, and TNF-α in cardiac tissues, as well as infiltration of CD11b + monocytes/macrophages with higher expression level of inflammatory cytokines. MI induced the great release of high mobility group protein B1 (HMGB1) and heat shock protein 60 (HSP60) in cardiac tissue. MiR-21 deficiency significantly promoted the inflammatory cytokine production triggered by DAMPs in macrophages, whereas, miR-21 overexpression markedly inhibited the inflammatory cytokine production. Mechanistically, miR-21 deficiency enhanced p38 and NF-κB signaling activation in cardiac tissue post MI and macrophages treated with DAMPs. MiR-21 was found to directly target kelch repeat and BTB (POZ) domain containing 7 (KBTBD7), which promoted DAMP-triggered inflammatory responses in macrophages. Furthermore, KBTBD7 interacted with MKK3/6 and promoted their activation, which in turn enhanced the activation of downstream p38 and NF-κB signaling induced by DAMPs. Therefore, our findings demonstrate that miR-21 attenuates inflammation, cardiac dysfunction, and maladaptive remodeling post MI through targeting KBTBD7 and inhibiting p38 and NF-κB signaling activation, suggesting that miR-21 may function as a novel potential therapeutic target for MI.

MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1.

MicroRNA-101 Inhibits Rat Cardiac Hypertrophy by Targeting Rab1a.

Overexpression of Microrna-99A Attenuates Heart Remodelling and Improves Cardiac Performance after Myocardial Infarction.

MicroRNA-101a Inhibits Cardiac Fibrosis Induced by Hypoxia Via Targeting TGFβRI on Cardiac Fibroblasts

MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7

MiR-101 Attenuates Myocardial Infarction-induced Injury by Targeting DDIT4 to Regulate Autophagy

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

MicroRNA-101 Protects Cardiac Fibroblasts from Hypoxia-Induced Apoptosis Via Inhibition of the TGF-β Signaling Pathway

MicroRNA-101a Protects Against the H2O2-induced Injury on Cardiomyocytes Via Targeting BCL2L11.

Microrna-451 Protects Against Cardiomyocyte Anoxia/Reoxygenation Injury by Inhibiting High Mobility Group Box 1 Expression

MicroRNA 21 Inhibits Left Ventricular Remodeling in the Early Phase of Rat Model with Ischemia-reperfusion Injury by Suppressing Cell Apoptosis

Overexpression of Microrna-145 Protects Against Rat Myocardial Infarction Through Targeting Pdcd4

Upregulated Expression of Mir-1/Mir-206 in a Rat Model of Myocardial Infarction.

MiR-467a-5p Aggravates Myocardial Infarction by Modulating ZEB1 Expression in Mice

Pharmacological inhibition of RUNX1 reduces infarct size after acute myocardial infarction in rats and underlying mechanism revealed by proteomics implicates repressed cathepsin levels

Overexpression of Microrna-99a Attenuates Cardiac Hypertrophy

Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.

miR-96-5p regulates myocardial infarction-induced cardiac fibrosis via Smad7/Smad3 pathway

SIRT1-dependent regulation of mitochondrial metabolism participates in miR-30a-5p-mediated cardiac remodeling post-myocardial infarction

MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.